UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000026777
Receipt number R000030666
Scientific Title Phase II trial of Lenvatinib in patients with metastatic or recurrent thymic carcinoma;REMORA trial (NCCH1508,REMORA trial)
Date of disclosure of the study information 2017/03/30
Last modified on 2022/04/06 09:40:12

No. Disposal Last modified on Item of update
1 Insert 2017/03/30 13:26:44
2 Update 2017/04/03 14:34:47 Key secondary outcomes
3 Update 2017/04/13 17:51:41 Recruitment status
4 Update 2017/04/13 17:57:09 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
5 Update 2017/04/25 08:17:05 Institutions
6 Update 2017/04/28 22:15:48 Institutions
7 Update 2017/06/20 15:59:16 Recruitment status
8 Update 2017/09/11 08:46:22 Recruitment status
9 Update 2017/12/28 09:13:36 UMIN ID1
10 Update 2018/02/13 10:45:18 Email
Last name of contact person
Last name of contact person
Division name
Division name
Email
Name of person sending information
Name of person sending information
Division name
Division name
Email
11 Update 2018/02/13 10:46:55 Public title
Public title
Acronym
Acronym
12 Update 2018/02/21 09:17:41 Recruitment status
13 Update 2018/03/01 09:54:39 Recruitment status
14 Update 2021/04/01 09:43:13 Recruitment status
Date of IRB
Last follow-up date
15 Update 2021/04/01 10:14:13 Publication of results
Number of participants that the trial has enrolled
Results
16 Update 2021/04/01 10:15:13 Results
17 Update 2021/04/26 10:15:29 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of person sending information
Name of person sending information
Organization
Organization
Address
Address
Tel
Email
18 Update 2022/04/06 09:40:12 Recruitment status